​Gene Therapy Market Insights 2025 - Trends, Growth Forecast & Leading Companies​ - Spark Therapeutics, Inc., Novartis AG, bluebird bio, Inc.

The latest report published by DataM Intelligence highlights the growth prospects of Gene Therapy market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/gene-therapy-market?sz

The Global Gene Therapy Market reached US$ 4.79 billion in 2024 and is expected to reach US$ 35.91 by 2033, growing at a CAGR of 23.1% during the forecast period 2025-2033.

The Gene Therapy Market involves the development and use of treatments that modify or replace faulty genes to cure or manage diseases. It offers promising solutions for genetic disorders, cancers, and rare conditions by targeting the root cause. This market is driven by scientific advancements, increasing R&D investments, and growing demand for personalized, long-lasting medical treatments.

Competitive Evaluation:

Companies covered in this report are Alnylam Pharmaceuticals, Inc., Spark Therapeutics, Inc., Novartis AG, bluebird bio, Inc., Ferring Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Sarepta Therapeutics, Inc., CSL Behring LLC, Amgen, Inc., Orchard Therapeutics group, Krystal Biotech, Inc. among Others.

The Gene Therapy Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

In September 2024, Vertex Pharmaceuticals Incorporated announced that Health Canada granted marketing authorization for CASGEVY (exagamglogene autotemcel), a genome-edited, autologous hematopoietic stem cell-based therapy, for patients aged 12 and older with sickle cell disease (SCD) experiencing recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta-thalassemia (TDT). The treatment represents a major step forward in gene therapy for hemoglobinopathies, with an estimated 2,000 eligible patients in Canada, the majority of whom are living with SCD.

In March 2024, Orchard Therapeutics, a company recently acquired by Kyowa Kirin, announced its U.S. launch plans for Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy for early-onset metachromatic leukodystrophy (MLD). MLD is a rare, severe neurodegenerative disorder that affects approximately 1 in 100,000 live births and typically progresses rapidly, leading to severe disability and early mortality. Lenmeldy offers a potentially transformative treatment option for affected children.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/gene-therapy-market

Gene Therapy Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Approach: Ex-Vivo, In-Vivo.

By Vector Type: Viral Vectors, Non-Viral Vectors.

By Technique: Gene Addition, Gene Silencing, Gene Editing.

By Application: Oncology, Musculoskeletal Conditions, Blood Disorders, Rare Diseases, Ophthalmology, Others.

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Gene Therapy market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Gene Therapy Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/gene-therapy-market

This report provides a 360-degree synopsis of the competitive scenario of the Gene Therapy industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/gene-therapy-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.